GlassScriptPhysician profile
Juan C Guarderas
NPI 1902893290
$4,059.89
in general payments reported to CMS, 2019-2025
24 companies · $1,072 in 2025
The $1,072 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.85 · 2020: $45.13 · 2021: $466 · 2022: $504 · 2023: $513 · 2024: $1,412 · 2025: $1,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,890 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,889.81 |
| Education | $107.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,074.92 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $1,057.75 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Csl Behring | $308.02 | 2022-2025 | Hizentra, Andembry, Haegarda |
| Astrazeneca Pharmaceuticals LP | $269.33 | 2021-2025 | Airsupra, Tezspire |
| Genzyme Corporation | $251.50 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $189.92 | 2020-2025 | Takhzyro, Cuvitru |
| Grifols USA, LLC | $168.73 | 2021-2024 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $147.87 | 2023-2024 | Xywav |
| Pfizer INC. | $115.34 | 2020-2025 | |
| Ars Pharmaceuticals Operations, INC. | $80.68 | 2025 | Neffy |
| Pharming Healthcare, INC. | $64.35 | 2021-2024 | Ruconest |
| Inspire Medical Systems, INC. | $49.51 | 2023-2024 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.43 | 2021-2023 | Ofev |
| Amgen INC. | $34.00 | 2025 | |
| United Therapeutics Corporation | $30.49 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocryst US Sales Co., LLC | $29.50 | 2023 | Orladeyo |
| Harmony Biosciences LLC | $28.77 | 2021 | |
| Philips North America LLC | $23.33 | 2024 | (Ak6) Vest Therapy |
| Aimmune Therapeutics, INC. | $21.29 | 2022 | |
| Baxter Healthcare | $20.76 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Actelion Pharmaceuticals US, INC. | $18.46 | 2024 | Opsumit |
| Teva Pharmaceuticals USA, INC. | $13.78 | 2021 | |
| Alk-Abello, INC | $12.51 | 2019 | |
| Inogen, INC. | $7.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Guarderas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.